AI brief of an SEC Form 8-K · AdaptHealth (AHCO)

AdaptHealth closes $1.1 billion credit facility, extends debt maturity to April 2031

Positive Impact 3 of 5 financing Written later

AdaptHealth and its subsidiary AdaptHealth LLC entered a credit agreement dated April 10, 2026, with Bank of America as administrative agent, and used it to repay the prior credit agreement from January 20, 2021. The new facility provides $450 million of revolving commitments, $325 million of initial term loans and $325 million of delayed draw term loans, and matures in April 2031. The company says the new terms carry lower pricing, and it does not expect the transaction to affect its full-year 2026 guidance.

Key points

  • Facility includes $450 million in revolving commitments, $325 million in initial term loans and $325 million in delayed draw term loans available for up to two years after closing.
  • Credit agreement dated April 10, 2026; scheduled maturity April 13, 2031, subject to a springing maturity 91 days before the 2028 Senior Notes mature if more than $15 million remains outstanding.
  • Proceeds repaid the prior credit agreement with Regions Bank; the company says the lowest pricing tier fell from 1.50% to 1.125% over SOFR.
  • The company does not expect the transaction to affect full-year 2026 guidance issued February 24, 2026.

The filing

CompanyAdaptHealth (AHCO)
Form8-K, current report
Filed with the SECApr 13, 2026, 8:11 AM ET
Accession number0001628280-26-024835

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.